Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial

BACKGROUND: Either benznidazole (BZN) or nifurtimox (NFX) is recommended as equivalent to treat Trypanosoma cruzi infection. Nonetheless, supportive data from randomised trials is limited to individuals treated with BZN in southern cone countries of Latin America. METHODS: The goal of this randomise...

Descripción completa

Detalles Bibliográficos
Autores principales: Villar, Juan Carlos, Herrera, Víctor Mauricio, Pérez Carreño, Juan Guillermo, Váquiro Herrera, Eliana, Castellanos Domínguez, Yeny Zulay, Vásquez, Skarlet Marcell, Cucunubá, Zulma Milena, Prado, Nilda Graciela, Hernández, Yolanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631895/
https://www.ncbi.nlm.nih.gov/pubmed/31307503
http://dx.doi.org/10.1186/s13063-019-3423-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631895/
https://www.ncbi.nlm.nih.gov/pubmed/31307503
http://dx.doi.org/10.1186/s13063-019-3423-3

Ejemplares similares